
Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival
Author(s) -
Huilin Ye,
Doudou Li,
Lin Q,
Yu Zhou,
Quanbo Zhou,
Bing Zeng,
Zhiqiang Fu,
Wenchao Gao,
Yimin Liu,
Ruiwan Chen,
Zhihua Liu,
Rufu Chen
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i21.6621
Subject(s) - immunohistochemistry , adenocarcinoma , medicine , biomarker , pathology , staining , stage (stratigraphy) , western blot , biology , cancer , gene , paleontology , biochemistry
To analyze RASSF6 expression in pancreatic ductal adenocarcinoma (PDAC) and to determine whether RASSF6 has an independent prognostic value in PDAC.